Back to Search
MICHAEL WAINBERG, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1487637732IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
36439(MN)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 1992
Research & Publications (20)
Perceived mental illness stigma and HIV risk behaviors among adult psychiatric outpatients in Rio de Janeiro, Brazil.
PMID 19543974·Community Ment Health J·2010
8-other
Sequencing of therapy to avoid resistance and the need for new antiretroviral drugs in the treatment of HIV disease.
PMID 19275705·Infect Disord Drug Targets·2009
6-review
Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
PMID 19626612·J Med Virol·2009
7-preclinical
Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).
PMID 19566959·J Int AIDS Soc·2009
8-other
Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance.
PMID 19210791·Retrovirology·2009
8-other
Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infection.
PMID 19171798·Antimicrob Agents Chemother·2009
8-other
Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men.
PMID 19634958·J Consult Clin Psychol·2009
4-observational
Antiretroviral drug resistance in human immunodeficiency virus type 2.
PMID 19470514·Antimicrob Agents Chemother·2009
6-review
Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.
PMID 19073730·J Virol·2009
8-other
Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2.
PMID 19064892·Antimicrob Agents Chemother·2009
8-other
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.
PMID 19223637·Antimicrob Agents Chemother·2009
8-other
The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.
PMID 19474106·J Virol·2009
7-preclinical
Isolation of drug-resistant mutant HIV variants using tissue culture drug selection.
PMID 19020842·Methods Mol Biol·2009
8-other
PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study.
PMID 19040279·J Med Virol·2008
4-observational
Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries.
PMID 19014657·J Int AIDS Soc·2008
8-other
Journal of the International AIDS Society: an important step forward.
PMID 19014655·J Int AIDS Soc·2008
8-other
Transmission networks of drug resistance acquired in primary/early stage HIV infection.
PMID 19005274·AIDS·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1487637732
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile